Urinary incontinence medical therapy: Difference between revisions
Kiran Singh (talk | contribs) |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Medications can reduce many types of leakage. Some drugs inhibit contractions of an overactive bladder. Others relax muscles, leading to more complete bladder emptying during urination. Some drugs tighten muscles at the bladder neck and urethra, preventing leakage. And some, especially hormones such as estrogen, are believed to cause muscles involved in urination to function normally. | Medications can reduce many types of leakage. Some drugs inhibit contractions of an overactive bladder. Others relax muscles, leading to more complete bladder emptying during urination. Some drugs tighten muscles at the bladder neck and urethra, preventing leakage. And some, especially hormones such as estrogen, are believed to cause muscles involved in urination to function normally.<ref name="pmid32644521">{{cite journal |vauthors=Tran LN, Puckett Y |title= |journal= |volume= |issue= |pages= |date= |pmid=32644521 |doi= |url=}}</ref><ref name="pmid29067433">{{cite journal |vauthors=Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L |title=Urinary Incontinence in Women: A Review |journal=JAMA |volume=318 |issue=16 |pages=1592–1604 |date=October 2017 |pmid=29067433 |doi=10.1001/jama.2017.12137 |url=}}</ref> | ||
===Pharmacotherapy=== | ===Pharmacotherapy=== | ||
In vaginal atrophy - topical or vaginal [[estrogen]]s; [[tolterodine]], [[oxybutynin]], [[propantheline]], [[darifenacin]], [[solifenacin]], trospium in urge incontinence, | In vaginal atrophy - topical or vaginal [[estrogen]]s; [[tolterodine]], [[oxybutynin]], [[propantheline]], [[darifenacin]], [[solifenacin]], trospium in urge incontinence, | ||
[[imipramine]] in mixed and stress urinary incontinence, [[pseudoephedrine]] and [[duloxetine]] in stress urinary incontinence. | [[imipramine]] in mixed and stress urinary incontinence, [[pseudoephedrine]] and [[duloxetine]] in stress urinary incontinence.<ref name="pmid8857788">{{cite journal |vauthors= |title=Managing acute and chronic urinary incontinence. AHCPR Urinary Incontinence in Adults Guideline Update Panel |journal=Am Fam Physician |volume=54 |issue=5 |pages=1661–72 |date=October 1996 |pmid=8857788 |doi= |url=}}</ref> | ||
Some of these medications can produce harmful side effects if used for long periods. In particular, estrogen therapy has been associated with an increased risk for cancers of the breast and [[endometrium]] (lining of the [[uterus]]). A patient should talk to a doctor about the risks and benefits of long-term use of medications. | Some of these medications can produce harmful side effects if used for long periods. In particular, estrogen therapy has been associated with an increased risk for cancers of the breast and [[endometrium]] (lining of the [[uterus]]). A patient should talk to a doctor about the risks and benefits of long-term use of medications. | ||
| Line 17: | Line 17: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category:Urology]] | [[Category:Urology]] | ||
Latest revision as of 15:16, 1 February 2021
|
Urinary incontinence Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urinary incontinence medical therapy On the Web |
|
American Roentgen Ray Society Images of Urinary incontinence medical therapy |
|
Risk calculators and risk factors for Urinary incontinence medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Medications can reduce many types of leakage. Some drugs inhibit contractions of an overactive bladder. Others relax muscles, leading to more complete bladder emptying during urination. Some drugs tighten muscles at the bladder neck and urethra, preventing leakage. And some, especially hormones such as estrogen, are believed to cause muscles involved in urination to function normally.[1][2]
Pharmacotherapy
In vaginal atrophy - topical or vaginal estrogens; tolterodine, oxybutynin, propantheline, darifenacin, solifenacin, trospium in urge incontinence, imipramine in mixed and stress urinary incontinence, pseudoephedrine and duloxetine in stress urinary incontinence.[3]
Some of these medications can produce harmful side effects if used for long periods. In particular, estrogen therapy has been associated with an increased risk for cancers of the breast and endometrium (lining of the uterus). A patient should talk to a doctor about the risks and benefits of long-term use of medications.
Pessaries
A pessary is a medical device that is inserted into the vagina. The most common kind is ring shaped, and is typically recommended to correct vaginal prolapse. The pessary compresses the urethra against the symphysis pubis and elevates the bladder neck. For some women this may reduce stress leakage. If a pessary is used, vaginal and urinary tract infections may occur and regular monitoring by a doctor is recommended.
References
- ↑ Tran LN, Puckett Y. PMID 32644521 Check
|pmid=value (help). Missing or empty|title=(help) - ↑ Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L (October 2017). "Urinary Incontinence in Women: A Review". JAMA. 318 (16): 1592–1604. doi:10.1001/jama.2017.12137. PMID 29067433.
- ↑ "Managing acute and chronic urinary incontinence. AHCPR Urinary Incontinence in Adults Guideline Update Panel". Am Fam Physician. 54 (5): 1661–72. October 1996. PMID 8857788.